6.71
0.06 (0.90%)
Penutupan Terdahulu | 6.65 |
Buka | 6.50 |
Jumlah Dagangan | 309,690 |
Purata Dagangan (3B) | 1,066,226 |
Modal Pasaran | 5,599,240,192 |
Harga / Pendapatan (P/E TTM) | 26.84 |
Harga / Pendapatan (P/E Ke hadapan) | 10.91 |
Harga / Jualan (P/S) | 0.580 |
Harga / Buku (P/B) | 0.710 |
Julat 52 Minggu | |
Tarikh Pendapatan | 12 May 2025 - 16 May 2025 |
Margin Keuntungan | 2.18% |
Margin Operasi (TTM) | 21.43% |
EPS Cair (TTM) | 0.250 |
Pertumbuhan Hasil Suku Tahunan (YOY) | 11.70% |
Pertumbuhan Pendapatan Suku Tahunan (YOY) | 76.90% |
Jumlah Hutang/Ekuiti (D/E MRQ) | 117.53% |
Nisbah Semasa (MRQ) | 2.66 |
Aliran Tunai Operasi (OCF TTM) | 902.17 M |
Aliran Tunai Bebas Leveraj (LFCF TTM) | 1.45 B |
Pulangan Atas Aset (ROA TTM) | 3.89% |
Pulangan Atas Ekuiti (ROE TTM) | 2.64% |
Arah Aliran Pasaran
Jangka Pendek | Jangka Sederhana | ||
Industri | Drug Manufacturers - General (US) | Bercampur | Menaik |
Drug Manufacturers - General (Global) | Bercampur | Menaik | |
Stok | Grifols, S.A. | Bercampur | Bercampur |
AISkor Stockmoo
Konsensus Penganalisis | NA |
Aktiviti Orang Dalam | NA |
Volatiliti Harga | 0.5 |
Purata Bergerak Teknikal | 0.0 |
Osilator Teknikal | -2.5 |
Purata | -0.67 |
As a vertically integrated plasma derivative producer, Spain-based Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portfolio, and following the firm's Biotest acquisition in April 2022, the biopharma business contributed 84% of sales in 2023. Grifols also has smaller segments including diagnostics (10% of sales) and biosupplies. |
|
Sektor | Healthcare |
Industri | Drug Manufacturers - General |
Gaya Pelaburan | Mid Growth |
% Dimiliki oleh Institusi | 56.13% |
Pemilikan
Nama | Tarikh | Syer Dipegang |
---|---|---|
Permian Investment Partners, Lp | 31 Dec 2024 | 16,187,321 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tarikh | Jenis | Butiran |
---|---|---|
14 Jan 2025 | Pengumuman | Grifols Pioneers High-Tech Analysis of Plasma Bank to Detect Early Signs of Parkinson’s Disease |
Purata Hasil Dividen 5T | 1.03% |
Tarikh EX | Tarikh Pengumuman | Tarikh Pembayaran | Perincian |
---|---|---|---|
03 Jun 2021 | 21 May 2021 | 14 Jun 2021 | 0.456586 Tunai |
30 Oct 2020 | 16 Oct 2020 | 09 Nov 2020 | 0.201439 Tunai |
02 Dec 2019 | 31 Oct 2019 | 11 Dec 2019 | 0.221872 Tunai |
07 Jun 2019 | 29 May 2019 | 18 Jun 2019 | 0.175638 Tunai |
30 Nov 2018 | 07 Nov 2018 | 11 Dec 2018 | 0.22789 Tunai |
01 Jun 2018 | 25 May 2018 | 12 Jun 2018 | 0.250975 Tunai |
01 Dec 2017 | - | 12 Dec 2017 | 0.212979 Tunai |
30 May 2017 | - | 08 Jun 2017 | 0.163528 Tunai |
05 Dec 2016 | - | 14 Dec 2016 | 0.193644 Tunai |
02 Jun 2016 | - | 15 Jun 2016 | 0.162059 Tunai |
10 Dec 2015 | - | 17 Dec 2015 | 0.384765 Tunai |
08 Jun 2015 | - | 15 Jun 2015 | 0.341846 Tunai |
04 Dec 2014 | - | 12 Dec 2014 | 0.312792 Tunai |
05 Jun 2013 | 24 May 2013 | 13 Jun 2013 | 0.258668 Tunai |
Papar semua |
Hasil Dividen Tahunan
Tahun | Dividen Tahunan ($) | Kekerapan/Tahun | Hasil % |
---|---|---|---|
2021 | 0.457 | 1 | 4.07 |
2020 | 0.201 | 1 | 1.09 |
2019 | 0.398 | 2 | 1.71 |
2018 | 0.479 | 2 | 2.61 |
2017 | 0.377 | 2 | 1.64 |
2016 | 0.356 | 2 | 2.21 |
2015 | 0.727 | 2 | 4.49 |
2014 | 0.313 | 1 | 1.84 |
2013 | 0.259 | 1 | 1.43 |
Papar semua |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
Keuntungan Nyata | - |
Keuntungan Tidak Nyata | - |
Dividen Diterima 2025 | - |
Jumlah Untung | - |
Pulangan Purata | - |
Kuantiti (Beli) | - |
Purata Harga (Beli) | - |
Kuantiti (Jual) | - |
Purata Harga (Jual) | - |